Anti-AMPAR limbic encephalitis as the initial presentation of metastatic small cell cancer
A small proportion of small cell lung cancer (SCLC) presents as paraneoplastic limbic encephalitis (PLE). The most implicated antibody is anti-Hu, but others such as anti-ampiphysin, anti-CRMP5 and anti-SOX1 have been frequently detected. Autoimmune encephalitis mediated by antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a rare but important neurological complication of SCLC. The incidence of SCLC presenting with anti-AMPAR antibody PLE is extremely low. Our case illustrates a rare presentation of SCLC with an intention to highlight the importance of evaluating for malignancy and associated paraneoplastic syndromes in patients with unexplained encephalopathy.
Authors
- Vishal Mehta (ORCID: https://orcid.org/0000-0001-9801-2445)
- Zhonglin Hao (ORCID: https://orcid.org/0000-0003-4638-0814)
- Nicole Lisek (ORCID: https://orcid.org/0009-0000-6518-2712)
- Chandra Kakarala
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- BMJ Case Reports
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1136/bcr-2025-268896
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00